{"name":"Allergy Therapeutics","slug":"allergy-therapeutics","ticker":"","exchange":"","domain":"allergy.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVWlhZTF3WHcwOWE5dGxjak5uQXBDN3FGSm9SaXkxaG1NdjYxQllQUjFaYkRpMXYtLTdZaHc3Wlk5TV9WbTBxS3VxUjNUOFJ2bkNybDZEb0dTRC0xYzV3eE1nZk1QNV8zcXplU0VVNG85UzEyT3BzaExnajltQVVFd1FNX0Q2X2lCODlXSGhnY1JDcE0?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Top Companies and Competitive Dynamics in the Allergy Immunotherapy Market - openPR.com","headline":"Top Companies and Competitive Dynamics in the Allergy Immunotherapy Market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-08","type":"pipeline","source":"The Manila Times","summary":"Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby - The Manila Times","headline":"Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOaU5fWi1lNUE5QUpxdDBfdmNYUnhfa0lucXJ5d3F4UnRvM3ljT2pzdVVRNHY3TUhLNDBOQ0hHdk5xOFN2Y0pZaTlCWGRVZ2R1VzZ1YWxldkhrdUJRdTBJZ0tRbDlSRXA2ak15ektmemhvNFMycG16eXVNYWdROXRnZTlVQnRJNEthaDRXRTdVNFk5ZjRa?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Allergic Rhinitis Market: Strong Pharma Growth Forecast Through 2034 - DelveInsight - openPR.com","headline":"Allergic Rhinitis Market: Strong Pharma Growth Forecast Through 2034 - DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-26","type":"deal","source":"medicaldialogues.in","summary":"GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline - medicaldialogues.in","headline":"GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPNTg3QjdQSGlCVDFGMWZaOE9GcXZhcDVVR2p4eUFINnY4M21nS0NPekg5TGVyRTk4RjRFbDV2Q0Q3Z0lMbFBielRoZmc1ZUk3M09SWGtqTkZ3ejh0V25MYmd6MmxyTFFmQjlVT1FjOUdDUHRPZ0l2V0hKZ2VwR1cwcVVyblY4emRCMDhUaml6UGhsS1hFRGc5Q0JnVnBpWkZrQ3RrckNzUkxMZ0Fm?oc=5","date":"2026-01-20","type":"deal","source":"statnews.com","summary":"GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B deal - statnews.com","headline":"GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQTktBaW50X1BGbWZ4NFRXbllkNGFiMTFYeDVTWWV5OXhKUmc4cWFtYVp4ZUVCLUZ5bWpiYUxXSDN2eGYwd2JsSGhjYkJ0ZHZXeEZHdkp4c0k4NUJ2NmNaQVB2SkdxRk9Jc1hERTFKZ2lWMWdaS3M0QnNyRDZpTWFISFZidGZyR0VLWXFzTFVmLVpLeWZndWlIdlhldHRYaUFvSUMwVkFsVkNFdkhY?oc=5","date":"2026-01-20","type":"pipeline","source":"Reuters","summary":"GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug - Reuters","headline":"GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOVhVV1pOUXhneXVhb3oycTltem9xTGJGX1ZfMnJTajBiZGNiLTNtZUtYZGU2Yy1iODBlY0M3XzNoVmNJZWdwX1o1YjRYajd5X0ZnVURUdTNRczlnbU5SWE9WdFoxWkVNWm4taGZHcFg3Y2VQOEZZRHpWMGdtQ200MVVDTkRYdWQ4ZGpxNkNOUzh2UUJEWnRIeGJkNGNfU3JrS2ZPUkVzTlJKdw?oc=5","date":"2026-01-20","type":"deal","source":"MedCity News","summary":"GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal - MedCity News","headline":"GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPY1BreTA3RjhoVGtudTFkQ3FsdmpqOEZhcDVFSHkxZi1pWXRBaGhQTElSbjF3czhqRnZpNG1tTGdnc001bEl5c2RPYUNlbU1Sb2w4VjVoTGc1aHM5dEhwVGIyeEwybjdCdDFQenBHaGg2X1NKYnBDZmF2Y19fOGFIYTBlNVE2ajRXdXZKWEJ2dW0tcTdsU3NvcVQxb2hlb1QwSGlTOGpfb3R4cHgz?oc=5","date":"2026-01-20","type":"trial","source":"Fierce Biotech","summary":"GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair - Fierce Biotech","headline":"GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOTU9aR09vTWp3czFaeUxfa0pDVTkwd0piZF9xeEN4eDR3N0ZWSzgyMDZLRVNPR0VLT0kteDNJdFdaZ1dBMHFPLUNxMm5rQ3JraFlTNFB6OVBDSTV6SENLTDZBZVVDZnZYWHpoSHlRbVhPVWsydG5hRW1jRlVzdUloQUYtSkgtZDRIejlBWHJ6RUE1Zw?oc=5","date":"2025-12-16","type":"pipeline","source":"pharmaphorum","summary":"Allergy Tx plots grass pollen jab launch after German okay - pharmaphorum","headline":"Allergy Tx plots grass pollen jab launch after German okay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOM1FCVW4xWnlQUy1CSWZQd1ZnY09BOU4xeUdGZmc5VjFFTENYX0p2OTJhUXEwVkNlTWNIZVZTb0xMQ0Fyako5UWxHZGJKcENDLU9HaGxTcmVnOE51dVdYa3pURkRuVTVncVRILVFiY3d5azV5ay1ZZzZzdjVKNFVmbWNrSmZhQmV0WHpWdkF5UzNzUWNQTlk3cTFJNHdQN0d3QXZBMnhVVDRfeV9UYzd1c2FFNG9JWEVkSU5FUi1ub3NYa0h4YTBGSWkwalRZV1lrNjFv?oc=5","date":"2025-12-16","type":"pipeline","source":"Proactive financial news","summary":"Allergy Therapeutics CEO on grass vaccine milestone and next steps - Proactive financial news","headline":"Allergy Therapeutics CEO on grass vaccine milestone and next steps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPTHVwSmRyZExBenR5NnlyLTVWNHdCd1RKT3BOR0ZFMHRfWW8wd1NVc3BSMlVEbFdLUUg3QkFtcEhlQXYwQ0gwMUNvdlFRU0c5N3NGZkJuTFR2cTNrT3lyOWRlVWM2NVBMXzNrYlYtUkEyWVVWMDhKdmx5eXNkRS03VlVoUlRWaG9iaVFjRF9sb3NTQVpmRnNwXzhtbVZ5UlktSWt1SWY3cHBFY2hOaExvRno1TF8xNnBacDFhMkxxWWRmNW44M0RTRkFjT05PVzNsb091QUhaV244ME1WeEg1eVNVc29ZMUgzMS11QlZJU1ZESDFnMndDcGlxbkt4ejlGRFNhRlpJMXFzV2RSOXZjejhfTXlnbHJobWxjdWxpVmloVFhtWlVUbEV3?oc=5","date":"2025-09-29","type":"trial","source":"GlobeNewswire","summary":"Peanut Allergy Clinical Trial Pipeline: Insights into a - GlobeNewswire","headline":"Peanut Allergy Clinical Trial Pipeline: Insights into a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxPSG5YRXZJMi0zbUlJZkNKZzVFVjVIb0lQSlVmZDlhWnc1a291VEJiWUFKWHNOMW5hckNKVmtJQXlvNWxvU3E3YnROcGRTRkNhbExNXzlWb0pFU0ZBeXZwdURkeXZFZ2JiUDBmQWtpUnJmamZiNWFCTEstb0puVmRiRWhHYXgyaXhBNnQxWGpyXzVSTl94Q3NiMm9rbGZCX2lJMHJud1ZheTRsY3hqTmU3OXEzSTFvb1BvTXh5Wm14bS1TZ3NFdXAxdlg4Y2o0SXppVGR5azkxTFk2TXFTZ0Iwa3ctaDl2UGVTM2YyM0NWVlVBemM0aVdWVDhoYVNza0x1c0IzemY4NFh3YmtiVV9Xa19JNmpyb2hXZ3pDXzg0TkdneU9OV1hic0lCN3IzMnNZUzlBRk1VM25RdjVFZGdnWXM3cDJMM2VVN09lQg?oc=5","date":"2025-09-03","type":"deal","source":"businesswire.com","summary":"Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair - businesswire.com","headline":"Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}